![]() |
Technical Data |
|
B5001-61C |
BTLA (B and T lymphocyte associated, BTLA1, CD272, FLJ16065, MGC129743, B and T lymphocyte attenuator) (PE) |
|
|
Description: BTLA, is a 70kD type I membrane glycoprotein that belongs to the CD28 family of receptors. CD28 receptors are Ig superfamily proteins, with an extracellular IgV-like domain, that function as co-stimulatory or co-inhibitory T cell signaling molecules. BTLA is expressed on B cells, T cells, and dendritic cells. Binding of BTLA to its ligand, herpesvirus entry mediator (HVEM, TNFRSF14) triggers a potent inhibitory signal that blocks T cell activation. The aa sequence of the extracellular domain of BTLA shares only 34% identity with that of mouse BTLA. A human BTLA variant lacking the transmembrane domain has been reported. Applications: Suitable for use in Flow Cytometry. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Absorption: 488nm Emission: 565-605nm Storage and Stability: May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for at least 12 months at 4°C. Freezing R-Phycoerythrin (PE) conjugates will result in a substantial loss of activity. PE conjugates are sensitive to light. |
|
|||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||